ATYR PHARMA ($ATYR) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.17 per share, beating estimates of -$0.19 by $0.02. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ATYR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ATYR PHARMA Insider Trading Activity
ATYR PHARMA insiders have traded $ATYR stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ATYR stock by insiders over the last 6 months:
- JANE A GROSS purchased 3,750 shares for an estimated $15,000
- JILL MARIE BROADFOOT (Chief Financial Officer) sold 1,254 shares for an estimated $4,740
- NANCY DENYES (General Counsel) sold 899 shares for an estimated $3,398
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
